• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition

$3,750.00 – $7,500.00

This report estimates U.S. consumer out-of-pocket spending on healthcare, particularly direct payments to providers and financed payments between 2020-2028.

Clear
SKU: 23-026 Categories: Healthcare Market Research, Insurance & Managed Care Tags: Consumer Out-of-Pocket Expenditures, Direct Pay and Co-Pay Expenditures, Elective Healthcare Expenses, Non-Elective Healthcare Expenses, Out-of-Pocket Healthcare Spending, Specialized Healthcare Financing Pages: 205
  • Description
  • Table of Contents
  • Latest reports

Description

A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing.

Total Expenditures

The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type, by payment method, by elective vs. non-elective).  Through the next five years, total consumer out-of-pocket expenditures for healthcare are expected to continue rising, with trends established over the past several years continuing through the foreseeable future. While the Covid pandemic of 2020 and 2021 caused a temporary pullback in consumer out-of-pocket healthcare spending, the historic trend resumed in 2022 and is expected to continue through the five year forecast period of this report.

The report presents the following data points:

  • Growth of Consumer Out-of-Pocket Expenditures 2018-2028, in $ Billion
  • How Consumer Out-of-Pocket Expenses Are Financed in 2022 (%) (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing, HSAs)
  • Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing 2018-2028, in $ Billion

Types and Amounts of Expenses Financed

In 2023, U.S. consumers financed many different types of healthcare expenses. These can broadly be grouped into two categories: elective procedures including over-the-counter (OTC) medications and non-elective procedures including prescription drugs. These types of procedures are distinct, and discussed separately within the report.

Elective procedures are those that are not strictly necessary to address a medical condition. They are thus not covered by medical insurance and their utilization is discretionary on the part of the consumer. The amount of non-elective healthcare and prescription drug expenses financed by individual consumers varies widely, although a very large proportion of consumers must finance some expenditures. The report provides the following data:

  • Methods of Financing Elective Procedures, 2022 (Credit Cards, Cash or Check, Healthcare Financing Programs, Loans or Lines of Credit)
  • Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Percentile of Total Health Spending, 2020
  • Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Type of Service, 2020 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care)
  • Distribution of Out-of-Pocket Healthcare Spending for the Average Person, 2020 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care)
  • Drug Cost Coverage by Payor Type (Public, Private, Cash) 1965, 1985, 2000, 2005, 2010, 2020

Consumers Who Pay Out-Of-Pocket

Consumers from all socioeconomic groups are facing high out-of-pocket expenditures for healthcare. Certain groups are more vulnerable than others to having trouble paying their medical bills and represent a larger proportion of this spending. These include the uninsured and underinsured, Medicaid recipients, disabled persons, senior citizens, the mentally ill, obese persons, people suffering from drug or alcohol addiction, persons with chronic medical conditions. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition provides the following related information:

  • Size of High Risk Groups for Out-of-Pocket Healthcare Expenditures, 2018-2028, in Millions of Persons (The Uninsured & Under-insured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Drug or Alcohol Addictions, Persons with Chronic Conditions)
  • Comparative Sizes of High Risk Groups for Out-of-Pocket Healthcare Expenditures, 2018-2028, in Millions of Persons (The Uninsured & Under-insured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Drug or Alcohol Addictions, Persons with Chronic Conditions)
  • Proportion of Adults under Age 65 with Chronic Conditions, 2023 (Privately Insured, Medicare or Medicaid, Uninsured, Other)

Expenditures by Type, Payment Methods, Elective vs. Non-Elective Procedures

Consumers in the United States utilize a variety of methods to pay for healthcare products and services, required in instances when payment is not made directly from a healthcare plan to the provider. The report examines expenditure by type, including direct payments and co-pays, and illustrates that the amount of out-of-pocket expenditures financed by consumers in the coming years will vary considerably between elective and non-elective procedures. Featured data include:

  • Change in Consumer Out-of-Pocket Expenditures by Type 2018-2028, in $ Billion (Direct Payments, Co-pays, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Spending by Type of Healthcare Expenditure, 2015, 2020, 2025 (Direct Payments, Co-pays)
  • Change in Consumer Out-of-Pocket Expenditure by Payment Type, 2018-2028, in $ Billion (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Expenditures by Payment Type, 2018, 2023, 2028 (Credit Cards, Cash or Check, FSAs, Loans or Lines of Credit, Healthcare Financing Programs, HSAs)
  • Growth of Consumer Out-of-Pocket Expenditures for Elective vs. Non-Elective Procedures, 2018-2028, in $ Billion (Elective, Non-Elective)
  • Change in Consumer Out-of-Pocket Expenditures for Elective Procedures That Are Financed, by Payment Type, 2018-2028, in $ Billion (Paid by Cash or Check, Financed, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Spending for Elective Procedures That Are Financed (All Methods), 2018, 2023, 2028 (Paid by Cash or Check, Financed)
  • Change in Amount of Consumer Out-of-Pocket Expenditures for Non-Elective Procedures That Are Financed, 2018-2028, in $ Billion (Paid by Cash or Check, Financed, Total, Change [%])
  • Proportion of Consumer Out-of-Pocket Spending for Non-Elective Procedures That Are Financed (All Methods), 2018, 2023, 2028 (Paid by Cash or Check, Financed)
  • Distribution of Out-of-Pocket Spending on Non-Elective Procedures for the Average Person, 2017 (Ill-defined conditions, Circulatory, Musculoskeletal, Respiratory, Endocrine, Nervous system, Cancers, Injury, Genitourinary, Digestive, Mental Illness, Other, Infectious diseases, Pregnancy and childbirth, Dermatological)

Market Drivers and Restraints

The strong growth in U.S. out-of-pocket spending is the result of a preponderance of market drivers, which are mitigated by relatively few market restraints. The report shows leading drivers and restraints of consumer out-of-pocket healthcare spending, in order of strength, across the market:

  • Drivers & Restraints of the Consumer Out-of-Pocket Spending Market
  • Drivers & Restraints of Direct Pay and Co-Pay Expenditures
  • Drivers & Restraints of Credit Cards, Cash/Check, FSA, Loan/Line of Credit, Healthcare Financing Program and HSA Expenditures
  • Drivers & Restraints of Elective Procedure Out-of-Pocket Expenditures
  • Drivers & Restraints of Non-Elective Procedure Out-of-Pocket Expenditures
  • Drivers & Restraints of Specialized Healthcare Financing
  • Drivers & Restraints of Specialized Healthcare Financing for Elective Procedures
  • Drivers & Restraints of Specialized Healthcare Financing for Non-Elective Procedures

Company Profiles

A large number of companies help consumers pay their out-of-pocket medical expenses and/or significantly influence those expenses. Most companies that provide patient financing focus on funding elective procedures, with a smaller number offering financing for non-elective therapies and providing other financial services. While companies participating in the credit card, and lines/lines of credit segment are numerous and do not specialize in healthcare products, the companies operating in the specialized healthcare financing are highly focused on financing medical and dental expenses. In general, the market is very dynamic, with many players entering and exiting. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition provides profiles of players in the market, noting history and lines of business, financial information, and relevant business operations. The companies profiled include:

  • Ally
  • Aurora Quick Care
  • CareCredit
  • CareSpot
  • ClearBalance
  • ClearGage
  • Concentra
  • Denefits
  • E-Financing Solutions
  • FastMed
  • Lending Club Patient Solutions
  • LendingUSA
  • MinuteClinic
  • NextCare
  • PatientFi
  • Prosper Healthcare Lending
  • RediClinic/Rite Aid Virtual Care
  • SimpleSelect Patient Finance
  • Wells Fargo

 

Table of Contents

Chapter 1: Executive Summary

Out-of-Pocket Expenditures in the U.S. Healthcare Industry

Scope and Methodology

Out-of-Pocket Spending Summary

  • Figure 1-1: Consumer Out-of-Pocket Expenditures, 2018-2028 ($ Billion)
  • Table 1-1: Consumer Out-of-Pocket Spending Market Drivers and Restraints, 2023
  • Figure 1-2: How Consumer Out-of-Pocket Expenses Are Financed in 2022, by Type Used (Cash or Check, Credit Cards, FSAs, Health Care Financing Programs, HSAs, Loans or Lines of Credit) (%)
  • Figure 1-3: Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing 2018-2028, ($ Billion)

 

Chapter 2: The U.S. Healthcare System in 2023

Healthcare System Overview

Background

Public Healthcare

Medicare

Medicaid

Veteran’s Administration

Children’s Health Insurance Program

Private Healthcare

Commercial Health Insurers

Blue Cross Blue Shield Plans

HMOs

Self-Funded Employee Health Plans

On Demand Healthcare

Urgent Care Centers

Retail Clinics

Other Healthcare Venues

Insufficient Focus on Wellness and Prevention

Cost Issues

U.S. Healthcare Spending

  • Table 2-1: Percent of U.S. National Healthcare Spending by Category (Hospital Care, Physician and Clinical Services, Prescription Drugs, Clinical Services, Nursing Care Facilities, Home Healthcare), 2021

Effects of Covid

U.S. Costs vs. Peer Country Costs

  • Figure 2-1:  Percent of GDP Spent on Health by OECD Member, 1980-2021

High Cost Variation by City and Venue

Healthcare Inflation

Managed Care Cost Shifting

Effects on Consumers

Balance Bills

No Surprises Act of 2020

Prior Plan Approval

Staffing Shortages

Physician Shortages

System Errors and Inefficiencies

The Effect of the Economy

  • Table 2-2: Key U.S. Economic Strength Measures, April 2023 vs. April 2022

Inflation

Widening Wage Gap

Reduced Savings Rate

Discontinued Stimulus Payments

Replacement of Workers by Technology

Forecasts

Disease Management and Wellness Programs

Regulation

  • Table 2-3: Selected U.S. Federal and State Healthcare Oversight Bodies, 2023

Reimbursement Challenges

MACRA and Value Based Reimbursement

Payment for Approved Assays

Consumer Healthcare Information

Consumer Information Online

DTC Ad Spending

Personal Health Records (PHRs)

Lower Cost Medications

Generic Drugs

Private-Label OTC Medications

Rx-to-OTC Switches

Affordable Care Act

Individual Mandate Repeal

Association Health Plans

Short Term Limited Duration Insurance (STLDI)

Impact of the ACA on Out-of-pocket Expenditures

Impact of Covid

Diagnostic Tests

Vaccines

Sick Care

Life Expectancy

 

Chapter 3: U.S. Out-of-Pocket Expenditures

Types of Expenditures

Insurance Co-Payments

Direct Payments

High Deductible Health Plans

Premiums and Plan Fees

Payment Methods

Cash, Check or Money Transfer

Credit Cards

Loans and Lines of Credit

Medical Financing

Flexible Spending Accounts

Health Savings Accounts

Types and Amounts of Expenses Financed

Elective Procedures and OTC Medications

  • Figure 3-1:  Methods of Financing Elective Procedures, by Method (Cash or Check, Credit Cards, Healthcare Financing Programs, Loans or Lines of Credit), 2022 (%)

Non-Elective Procedures and Prescription Drugs

  • Figure 3- 2:  Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Percentile of Total Health Spending, 2020 (%)
  • Figure 3-3: Average Share of Non-Elective Healthcare Expenses Paid Out-of-Pocket by Type of Service (Dental, Emergency Room, Home Health, Hospital, Office Based Visit, Outpatient, Other Health Care, Prescription Drugs, Vision), 2020 (%)
  • Figure 3-4:  Distribution of Out-of-Pocket Healthcare Spending for the Average U.S. Person, by Type (Dental, Emergency Room, Home Health, Hospital, Office Based Visit, Outpatient, Other Health Care, Prescription Drugs, Vision), 2020 (%)
  • Figure 3-5: Drug Cost Coverage, by Payor Type (Public, Private, Cash), 1965, 1985, 2000, 2005, 2010, 2020 (%)

Consumers Who Pay Out-Of-Pocket

  • Table 3-1: Size of High Risk Groups for Out-of-Pocket Healthcare Expenditures, (The Disabled, Medicaid Recipients, The Mentally Ill, Millennials, The Obese, Persons with Chronic Conditions, Persons with Drug or Alcohol Addictions, Senior Citizens, The Uninsured & Under-insured), 2018-2028 (Millions of Persons)
  • Figure 3-6: Comparative Sizes of High Risk Groups for Out-of-Pocket Healthcare Expenditures, by Group (The Disabled, Medicaid Recipients, The Mentally Ill, Millennials, The Obese, Persons with Chronic Conditions, Persons with Drug or Alcohol Addictions, Senior Citizens, The Uninsured & Under-insured), 2018–2028 (Millions of Persons)

The Uninsured and Underinsured

The Uninsured

  • Figure 3-7: Percentage Distribution of Working Age Adults Who Were Uninsured for One or More Years, by Age (19-34, 35-49, 50-64), Race (Black, Latino/Hispanic, White), Income (<200% FPL, 200% FPL+), Health Status (Sicker, Not Sticker) and Region (Northeast, Midwest, South, West), 2022 (%)

The Underinsured

  • Figure 3-8: Percentage Distribution of Working Age Adults Who Were Underinsured for One or More Years, by Income (<200% FPL, 200% FPL) and Health Status (Sicker, Not Sicker), 2022 (%)

Medicaid Recipients

The Disabled

Disabled Veterans

Millennials

Senior Citizens

The Mentally Ill

The Obese

Persons with Alcohol and Drug Addictions

Persons with Chronic Conditions

  • Figure 3-9: Proportion of Adults Under Age 65 With Chronic Conditions, by Insurance Type (Medicare or Medicaid, Privately Insured, Uninsured, Other), 2023 (%)

 

Chapter 4: Consumer Out-of-Pocket Spending Forecasts in the U.S.

Forecasts

Total Expenditures

  • Table 4-1: Consumer Out-of-Pocket Expenditures, 2018-2028 ($ Billion)
  • Figure 4-1: Growth of Consumer Out-of-Pocket Expenditures, 2018-2028 ($ Billion)

Drivers & Restraints

  • Figure 4-2: Drivers & Restraints of Consumer Out-of-Pocket Expenditures, 2023

Expenditures by Type

  • Table 4-2: Consumer Out-of-Pocket Expenditures, by Type (Co-Pays, Direct Payments), 2018-2028  ($ Billion)
  • Figure 4-3: Change in Consumer Out-of-Pocket Expenditures, by Type (Co-Pays, Direct Payments),  2018-2028 ($ Billion)
  • Figure 4-4: Proportion of Consumer Out-of-Pocket Spending, by Type of Healthcare Expenditure  (Co-Pays, Direct Payments), 2018, 2023, 2028 (%)

Drivers & Restraints

  • Figure 4-5: Drivers & Restraints of Direct Pay and Co-Pay Expenditures, 2023

Payment Methods

  • Table 4-3: Consumer Out-of-Pocket Expenditure, by Payment Type (Cash or Check, Credit Cards, FSAs, Healthcare Financing Programs, HSAs, Loans or Lines of Credit), 2018-2028, ($ Billion)
  • Figure 4-6: Change in Consumer Out-of-Pocket Expenditure, by Payment Type (Cash or Check, Credit Cards, FSAs, Healthcare Financing Programs, HSAs, Loans or Lines of Credit), 2018-2028 ($ Billion)
  • Figure 4-7: Proportion of Consumer Out-of-Pocket Expenditures, by Payment Type (Cash or Check, Credit Cards, FSAs, Healthcare Financing Programs, HSAs, Loans or Lines of Credit), 2018, 2023, 2028 (%)

Drivers & Restraints

  • Figure 4-8: Drivers & Restraints of Credit Cards, Cash/Check, FSA, Loan/Line of Credit, Healthcare Financing Program and HSA Expenditures, 2023

Total Financing of Elective vs. Non-Elective Procedures

  • Table 4-4: Consumer Out-of-Pocket Expenditures for Elective vs. Non-Elective Procedures, 2018-2028  ($ Billion)
  • Figure 4-9: Growth of Consumer Out-of-Pocket Expenditures for Elective vs. Non-Elective Procedures, 2018-2028 ($ Billion)

Elective Procedures

  • Table 4-5: Consumer Out-of-Pocket Expenditures for Elective Procedures That Are Financed, by Payment Type (Paid by Cash or Check, Financed), 2018-2028 ($ Billion)
  • Figure 4-10: Change in Consumer Out-of-Pocket Expenditures for Elective Procedures, by Payment Type (Paid by Cash or Check, Financed), 2018-2028, ($ Billion)
  • Figure 4-11: Proportion of Consumer Out-of-Pocket Spending for Elective Procedures That Are Financed (All Methods), by Method (Paid by Cash or Check, Financed), 2018, 2023, 2028 (%)

Drivers & Restraints

  • Figure 4-12: Drivers & Restraints of Elective Procedure Out-of-Pocket Expenditures, 2023

Non-Elective Procedures

  • Table 4-6: Amount of Consumer Out-of-Pocket Expenditures for Non-Elective Procedures That Are Financed, by Payment Type (Paid by Cash or Check, Financed), 2018-2028 ($ Billion)
  • Figure 4-13: Change in Consumer Out-of-Pocket Expenditures for Non-Elective Procedures, by Payment Type (Paid by Cash or Check, Financed), 2018-2028 ($ Billion)
  • Figure 4-14: Proportion of Consumer Out-of-Pocket Spending for Non-Elective Procedures That Are Financed (All Methods), by Payment Type (Paid by Cash or Check, Financed), 2018, 2023, 2028 (%)
  • Figure 4-15: Distribution of Out-of-Pocket Spending on Non-Elective Procedures for the Average Person, by Procedure (Cancers and Tumors, Circulatory System, Dermatological, Digestive, Endocrine, Genitourinary, Ill Defined Conditions, Infectious Diseases, Injury and Poisoning, Mental Illness, Musculoskeletal, Nervous System, Pregnancy and Childbirth, Respiratory, Other), 2017 (%)

Drivers & Restraints

  • Figure 4-16: Drivers & Restraints of Non-Elective Procedure Out-of-Pocket Expenditures, 2023

 

Chapter 5: Specialized Healthcare Financing

Introduction

Patient Population

Improving Collections

Market Expansion

Customer Satisfaction

Types of Procedures Financed

Elective Procedures

  • Figure 5-1: Share of Medical Procedure Financing Market, by Major Segment (Chiropractic Services, Cosmetic Dentistry, Cosmetic Surgery, Fertility Treatment, Hair Restoration, Vision Correction, Weight Loss Surgery, Others), 2023

Cosmetic Surgery

  • Table 5-1: Cosmetic Surgical Procedures Offered in the U.S., by Type (Invasive, Minimally Invasive,  Non-Invasive), 2023

Cosmetic Dentistry

Chiropractic Services

Fertility Treatments

  • Table 5-2: Fertility Treatments Offered in the U.S., 2023

Weight Loss Surgery

  • Table 5-3: Leading Weight Reduction Surgeries Offered in the U.S., 2023

Vision Correction

Hair Restoration

Other Procedures

Non-Elective Procedures

Types of Products

Costs to Consumers

Costs to Providers

Usage and Acceptance

Industry Exits

 

Chapter 6: Specialized Healthcare Financing Forecasts

Total Expenditures

  • Table 6-1: Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing, 2018-2028  ($ Billion)
  • Figure 6-1: Growth of Consumer Out-of-Pocket Expenditures Paid with Specialized Healthcare Financing, 2018-2028 ($ Billion)

Drivers & Restraints

  • Figure 6-2: Drivers & Restraints of Specialized Healthcare Financing, 2023

Elective Procedures

  • Table 6-2: Segmentation of Selected Medical Finance Companies in the U.S., 2023
  • Table 6-3: Consumer Out-of-Pocket Elective Procedure Expenditures Paid with Specialized Healthcare Financing, 2018-2028 ($ Billion)
  • Figure 6-3: Growth of Consumer Out-of-Pocket Elective Procedure Expenditures Paid with Specialized Healthcare Financing, 2018-2028 ($ Billion)

Drivers & Restraints

  • Figure 6-4: Drivers & Restraints of Specialized Healthcare Financing for Elective Procedures, 2023

Non-Elective Procedures

  • Table 6-4: Consumer Out-of-Pocket Non-Elective Procedure Expenditures Paid with Specialized Healthcare Financing, 2018-2028 ($ Billion)
  • Figure 6-5: Growth of Consumer Out-of-Pocket Non-Elective Procedure Expenditures Paid with Specialized Healthcare Financing, 2018-2028 ($ Billion)

Drivers & Restraints

  • Figure 6-6: Drivers & Restraints of Specialized Healthcare Financing for Non-Elective Procedures, 2023

Key Players

  • Table 6-5: Leading Providers of Specialized Healthcare Financing, by Company (Ally, CareCredit, ClearBalance, ClearGage, GreenSky, Lending Club, Lending USA, Prosper Healthcare, Wells Fargo, Others), 2022 ($ Billion)
  • Figure 6-7: Market Positions of Leading Providers of Specialized Healthcare Financing, by Company (Ally, CareCredit, ClearBalance, ClearGage, GreenSky, Lending Club, Lending USA, Prosper Healthcare, Wells Fargo, Others), 2022 (%)

 

Chapter 7: Efforts to Contain Out-of-Pocket Spending

Introduction

Industry

Tele-Health

Mobile Health

Artificial Intelligence

Chatbots and ChatGPT

Future Applications

Consumer Education

Government

Federal Government

Inflation Reduction Act

State Governments

Premium Rate Review

Reference-Based Pricing

Cost Growth Benchmarks

Reblancing

CalAIM

Consumer Groups, Community Organizations and Others

 

Chapter 8: Company Profiles

Ally

History and Lines of Business

Financial Information

Relevant Business Operations

Aurora Quick Care

History and Lines of Business

Financial Information

Relevant Business Operations

CareCredit

History and Lines of Business

Financial Information

Relevant Business Operations

ClearBalance

History and Lines of Business

Financial Information

Relevant Business Operations

ClearGage

History and Lines of Business

Financial Information

Relevant Business Operations

Concentra

History and Lines of Business

Financial Information

Relevant Business Operations

Denefits

History and Lines of Business

Financial Information

Relevant Business Operations

E-Financing Solutions

History and Lines of Business

Financial Information

Relevant Business Operations

FastMed

History and Lines of Business

Financial Information

Relevant Business Operations

GreenSky/Goldman Sachs

History and Lines of Business

Financial Information

Relevant Business Operations

Lending Club Patient Solutions

History and Lines of Business

Financial Information

Relevant Business Operations

LendingUSA

History and Lines of Business

Financial Information

Relevant Business Operations

MinuteClinic

History and Lines of Business

Financial Information

Relevant Business Operations

NextCare

History and Lines of Business

Financial Information

Relevant Business Operations

PatientFi

History and Lines of Business

Financial Information

Relevant Business Operations

Prosper Healthcare Lending

History and Lines of Business

Financial Information

Relevant Business Operations

RediClinic/Rite Aid Virtual Care

History and Lines of Business

Financial Information

Relevant Business Operations

SimpleSelect Patient Finance

History and Lines of Business

Financial Information

Relevant Business Operations

Wells Fargo

History and Lines of Business

Financial Information

Relevant Business Operations

    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
    November 29, 2023
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023
    Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
    July 13, 2023

Related products

  • Placeholder image

    Long-Term Care Market – Nursing Homes, Home Care, Hospice Care, and Assisted Living, The

    $3,995.00 – $7,990.00
  • Placeholder image

    Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, The

    $3,500.00 – $7,000.00
  • Placeholder image

    Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets, The

    $995.00 – $1,990.00
  • Placeholder image

    Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

    $3,995.00 – $7,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and... The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
Scroll to top